Arch Size Study for Anatomical Variations
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-100
SponsorIRCCS San Raffaele
About this trial
The aortic arch with a common origin of the innominate and left carotid artery (CILCA) prevalence in the general population is 13.6%. Its reputation as a benign anatomical variant has been ultimately shattered by further studies that identified the CILCA arch as a potential marker for thoracic aortic disease (TAD) The aim of this work is to report the CT anatomical characteristics of the aortic arch in subjects with or without aneurysms requiring treatment, in 5 major European cardiovascular centers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
The population of the study is the general population undergoing Angio CT scan both the thoracic aorta
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsGroup A: Non aneurysm patients
Group B: Aneurysm patients
Trial outcomes
Primary outcomes
1
difference from baseline of aortic arch anomalies
record of anatomical variations of the aortic arch
Time frame
30 daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov